Showing Results for: “Glycemic Index and Diabetes”

The American Diabetes Association ® (ADA) welcomes the 2024 principal officers and board of directors. The 15-member board is comprised of forward-thinking and innovative medical, scientific, education, and executive business professionals who will strategically lead and focus efforts to ensure the ADA continues to advance the mission upon which it was founded. "We are so excited to announce our 2024 board of directors,” said Charles “Chuck” Henderson, the ADA’s chief executive officer. “We look forward to the insight and skills each of these thought leaders will provide to help move the

Whole Body Digital Twin Technology Enables Personalized Approach to Help Improve Disrupted Metabolism for Individuals with Type 2 Diabetes A new study powered by artificial intelligence (AI), Whole Body Digital Twin, reveals the highest reported rate of remission of type 2 diabetes to date. The findings were presented as a late-breaking poster session at the 82nd Scientific Sessions of the American Diabetes Association® (ADA) in New Orleans, LA. For individuals with type 2 diabetes, remission is defined as sustaining normal blood glucose (blood sugar) levels for at least three months without

Diabetes Study Adds to Growing Body of Data Around Risk Factors for Long-Standing Effects of COVID-19 Infection A new study reveals that diabetes is a potential risk factor for post-acute sequelae of COVID-19 (PASC), also known as long COVID-19, a range of post-COVID-19 symptoms such as brain fog, skin conditions, depression, and shortness of breath. The findings were presented as a late-breaking poster session at the 82nd Scientific Sessions of the American Diabetes Association® (ADA) in New Orleans, LA. Research shows that up to 10 to 30 percent of individuals that had COVID-19 may

Public health crisis makes lack of access to healthy food, medical appointments worse for minority groups According to a national survey released by the American Diabetes Association ® (ADA) in partnership with the real-time market research platform Thrivable, those with diabetes reported financial, housing, food and medical access challenges of crisis proportions, at numbers well beyond the impact on the public at large. Fully 7.6% of respondents said they had become temporarily or permanently homeless since the start of the public health emergency–a figure 48 times higher than the national

Project Aims to Remove Barriers to Care to Help Prevent Vision Loss Today, the American Diabetes Association ® (ADA) and Genentech, a member of the Roche Group, announced a new partnership as part of the ADA’s Health Equity Now work to tackle access to screening and treatment for eye diseases that affect the diabetes community. Diabetes is the leading cause of vision loss in people 18–64 years old, and African Americans, American Indians, Alaska Natives, Hispanics/Latinos, and older adults living with diabetes are at higher risk of losing their vision or going blind. 1 Comprehensive eye exams

Today, The American Diabetes Association ® (ADA) announced its recognition as a winner in the 2022 Sharecare Awards in the category of chronic diseases for The Big Step Up: Detection that encourages people to take the big step up for their health. Sharecare (Nasdaq: SHCR ), in association with The National Academy of Television Arts & Sciences, New York Chapter (NY NATAS), the Sharecare Awards promote and reward excellence for the best productions and programming in health and well-being. Each year for Diabetes Awareness Month, the ADA curates a national campaign geared towards motivating